Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens

Acta Tropica

Volumn 142, Issue , 2015, Pages 47-56

  Noland, Gregory S ^a   Jansen, Paul ^a   Vulule, John M ^b   Park, Gregory S ^a   Ondigo, Bartholomew N ^b   Kazura, James W ^c   Moormann, Ann M ^d   John, Chandy C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antibodies; Blood stage antigen; Immunity; Malaria; Pre erythrocytic antigen; Subclass

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; BIOLOGICAL MARKER; CIRCUMSPOROZOITE PROTEIN; ERYTHROCYTE ANTIGEN; ERYTHROCYTE BINDING ANTIGEN 175; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4; LIVER STAGE ANTIGEN 1; MEROZOITE SURFACE PROTEIN 1; THROMBOSPONDIN RELATED ADHESIVE PROTEIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ANTIBODY; ANTIGEN; BIOMARKER; DISEASE PREVALENCE; DISEASE TRANSMISSION; IMMUNITY; MALARIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY RESPONSE; ANTIBODY SCREENING; ANTIGEN DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; DISEASE TRANSMISSION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INFECTION RISK; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; SEX DIFFERENCE; AGE; AGED; BIOSYNTHESIS; BLOOD; ERYTHROCYTE; IMMUNOLOGY; MALARIA, FALCIPARUM; MIDDLE AGED; TRANSMISSION; VERY ELDERLY; YOUNG ADULT;

KENYA;

PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN G; KENYA; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PREVALENCE; YOUNG ADULT;

EID: 84918537204     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2014.10.011     Document Type: Article

References (53)

1. Afridi S., Atkinson A., Garnier S., Fumoux F., Rihet P. Malaria resistance genes are associated with the levels of IgG subclasses directed against Plasmodium falciparum blood-stage antigens in Burkina Faso. Malar. J. 2012, 11:308.
2. Aribot G., Rogier C., Sarthou J.L., Trape J.F., Balde A.T., Druilhe P., Roussilhon C. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). Am. J. Trop. Med. Hyg. 1996, 54:449-457.
3. Baum E., Badu K., Molina D.M., Liang X., Felgner P.L., Yan G. Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenya highland sites with differing transmission levels. PLOS ONE 2013, 8(12):e82246.
4. Beier J.C., Perkins P.V., Onyango F.K., Gargan T.P., Oster C.N., Whitmire R.E., Koech D.K., Roberts C.R. Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J. Med. Entomol. 1990, 27:570-577.
5. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T., Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 1990, 172:1633-1641.
6. Bouharoun-Tayoun H., Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 1992, 60:1473-1481.
7. Campbell J.M. Malaria in the Uasin Gishu and the Trans Nzoia, Kenya. East Afr. Med. J. 1929, 6:32-43.
8. Chelimo K., Ofulla A.V., Narum D.L., Kazura J.W., Lanar D.E., John C.C. Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya. Pediatr. Infect. Dis. J. 2005, 24:680-684.
9. Chougnet C., Lepers J.P., Astagneau P., Rason M.D., Savel J., Deloron P. Lymphoproliferative responses to synthetic peptides from merozoite ring-infected erythrocyte surface antigen and circumsporozoite protein: a longitudinal study during a falciparum malaria episode. Am. J. Trop. Med. Hyg. 1991, 45:560-566.
10. Cohen S., Mc G.I., Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
11. Courtin D., Oesterholt M., Huismans H., Kusi K., Milet J., Badaut C., Gaye O., Roeffen W., Remarque E.J., Sauerwein R., Garcia A., Luty A.J. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. PLoS ONE 2009, 4:e7590.
12. Dobano C., Quelhas D., Quinto L., Puyol L., Serra-Casas E., Mayor A., Nhampossa T., Macete E., Aide P., Mandomando I., Sanz S., Puniya S.K., Singh B., Gupta P., Bhattacharya A., Chauhan V.S., Aponte J.J., Chitnis C.E., Alonso P.L., Menendez C. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children. Clin. Vaccin. Immunol. 2012, 19:157-166.
13. Dodoo D., Aikins A., Kusi K.A., Lamptey H., Remarque E., Milligan P., Bosomprah S., Chilengi R., Osei Y.D., Akanmori B.D., Theisen M. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar. J. 2008, 7:142.
14. Duah N.O., Miles D.J., Whittle H.C., Conway D.J. Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort. Parasite Immunol. 2010, 32:125-134.
15. Duah N.O., Weiss H.A., Jepson A., Tetteh K.K., Whittle H.C., Conway D.J. Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens. PLoS ONE 2009, 4:e7381.
16. Egan A.F., Chappel J.A., Burghaus P.A., Morris J.S., McBride J.S., Holder A.A., Kaslow D.C., Riley E.M. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect. Immun. 1995, 63:456-466.
17. Ferrante A., Rzepczyk C.M. Atypical IgG subclass antibody responses to Plasmodium falciparum asexual stage antigens. Parasitol. Today 1997, 13:145-148.
18. Fidock D.A., Gras-Masse H., Lepers J.P., Brahimi K., Benmohamed L., Mellouk S., Guerin-Marchand C., Londono A., Raharimalala L., Meis J.F., et al. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J. Immunol. 1994, 153:190-204.
19. Gruner A.C., Brahimi K., Letourneur F., Renia L., Eling W., Snounou G., Druilhe P. Expression of the erythrocyte-binding antigen 175 in sporozoites and in liver stages of Plasmodium falciparum. J. Infect. Dis. 2001, 184:892-897.
20. Hay S.I., Noor A.M., Simba M., Busolo M., Guyatt H.L., Ochola S.A., Snow R.W. Clinical epidemiology of malaria in the highlands of western Kenya. Emerg. Infect. Dis. 2002, 8:543-548.
21. John C.C., McHugh M.M., Moormann A.M., Sumba P.O., Ofulla A.V. Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya. Trans. R. Soc. Trop. Med. Hyg. 2005, 99:780-786.
22. John C.C., Moormann A.M., Pregibon D.C., Sumba P.O., McHugh M.M., Narum D.L., Lanar D.E., Schluchter M.D., Kazura J.W. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am. J. Trop. Med. Hyg. 2005, 73:222-228.
23. John C.C., Moormann A.M., Sumba P.O., Ofulla A.V., Pregibon D.C., Kazura J.W. Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria. Infect. Immun. 2004, 72:5135-5142.
24. John C.C., Riedesel M.A., Magak N.G., Lindblade K.A., Menge D.M., Hodges J.S., Vulule J.M., Akhwale W. Possible interruption of malaria transmission, highland Kenya, 2007-2008. Emerg. Infect. Dis. 2009, 15:1917-1924.
25. John C.C., Tande A.J., Moormann A.M., Sumba P.O., Lanar D.E., Min X.M., Kazura J.W. Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J. Infect. Dis. 2008, 197:519-526.
26. John C.C., Zickafoose J.S., Sumba P.O., King C.L., Kazura J.W. Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya. Infect. Immun. 2003, 71:4320-4325.
27. Joos C., Marrama L., Polson H.E., Corre S., Diatta A.M., Diouf B., Trape J.F., Tall A., Longacre S., Perraut R. Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS ONE 2010, 5:e9871.
28. Kinyanjui S.M., Bull P., Newbold C.I., Marsh K. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J. Infect. Dis. 2003, 187:667-674.
29. Kitua A.Y., Urassa H., Wechsler M., Smith T., Vounatsou P., Weiss N.A., Alonso P.L., Tanner M. Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates. Parasite Immunol. 1999, 21:307-317.
30. Matson A.T. The history of malaria in Nandi. East Afr. Med. J. 1957, 34:431-441.
31. Metzger W.G., Okenu D.M., Cavanagh D.R., Robinson J.V., Bojang K.A., Weiss H.A., McBride J.S., Greenwood B.M., Conway D.J. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol. 2003, 25:307-312.
32. Moormann A.M., Embury P.E., Opondo J., Sumba O.P., Ouma J.H., Kazura J.W., John C.C. Frequencies of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency differ in highland and nearby lowland malaria-endemic areas of Kenya. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:513-514.
33. Ndungu F.M., Bull P.C., Ross A., Lowe B.S., Kabiru E., Marsh K. Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol. 2002, 24:77-82.
34. Nebie I., Diarra A., Ouedraogo A., Soulama I., Bougouma E.C., Tiono A.B., Konate A.T., Chilengi R., Theisen M., Dodoo D., Remarque E., Bosomprah S., Milligan P., Sirima S.B. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect. Immun. 2008, 76:759-766.
35. Noland G.S., Hendel-Paterson B., Min X.M., Moormann A.M., Vulule J.M., Narum D.L., Lanar D.E., Kazura J.W., John C.C. Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission. Infect. Immun. 2008, 76:5721-5728.
36. Okiro E.A., Al-Taiar A., Reyburn H., Idro R., Berkley J.A., Snow R.W. Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar. J. 2009, 8:4.
37. Pleass R.J., Woof J.M. Fc receptors and immunity to parasites. Trends Parasitol. 2001, 17:545-551.
38. Reyburn H., Mbatia R., Drakeley C., Bruce J., Carneiro I., Olomi R., Cox J., Nkya W.M., Lemnge M., Greenwood B.M., Riley E.M. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA 2005, 293:1461-1470.
39. Richards J.S., Stanisic D.I., Fowkes F.J., Tavul L., Dabod E., Thompson J.K., Kumar S., Chitnis C.E., Narum D.L., Michon P., Siba P.M., Cowman A.F., Mueller I., Beeson J.G. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 2010, 51:e50-e60.
40. Rolfes M.A., McCarra M., Magak N.G., Ernst K.C., Dent A.E., Lindblade K.A., John C.C. Development of clinical immunity to malaria in highland areas of low and unstable transmission. Am. J. Trop. Med. Hyg. 2012, 87:806-812.
41. Roussilhon C., Oeuvray C., Muller-Graf C., Tall A., Rogier C., Trape J.F., Theisen M., Balde A., Perignon J.L., Druilhe P. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med. 2007, 4:e320.
42. Sarr J.B., Samb B., Sagna A.B., Fortin S., Doucoure S., Sow C., Senghor S., Gaayeb L., Guindo S., Schacht A.M., Rogerie F., Hermann E., Dia I., Konate L., Riveau G., Remoue F. Differential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites. Trans. R. Soc. Trop. Med. Hyg. 2012, 106:460-467.
43. Sarthou J.L., Angel G., Aribot G., Rogier C., Dieye A., Toure Balde A., Diatta B., Seignot P., Roussilhon C. Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria. Infect. Immun. 1997, 65:3271-3276.
44. Shanks G.D., Biomndo K., Hay S.I., Snow R.W. Changing patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlands. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:253-255.
45. Shi Y.P., Sayed U., Qari S.H., Roberts J.M., Udhayakumar V., Oloo A.J., Hawley W.A., Kaslow D.C., Nahlen B.L., Lal A.A. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect. Immun. 1996, 64:2716-2723.
46. Silvie O., Franetich J.F., Charrin S., Mueller M.S., Siau A., Bodescot M., Rubinstein E., Hannoun L., Charoenvit Y., Kocken C.H., Thomas A.W., Van Gemert G.J., Sauerwein R.W., Blackman M.J., Anders R.F., Pluschke G., Mazier D. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem. 2004, 279:9490-9496.
47. Snow R.W., Omumbo J.A., Lowe B., Molyneux C.S., Obiero J.O., Palmer A., Weber M.W., Pinder M., Nahlen B., Obonyo C., Newbold C., Gupta S., Marsh K. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997, 349:1650-1654.
48. Soe S., Theisen M., Roussilhon C., Aye K.S., Druilhe P. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect. Immun. 2004, 72:247-252.
49. Stanisic D.I., Richards J.S., McCallum F.J., Michon P., King C.L., Schoepflin S., Gilson P.R., Murphy V.J., Anders R.F., Mueller I., Beeson J.G. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect. Immun. 2009, 77:1165-1174.
50. Taylor R.R., Allen S.J., Greenwood B.M., Riley E.M. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 1998, 58:406-413.
51. Tebo A.E., Kremsner P.G., Luty A.J.F. Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp. Parasit. 2001, 98:20-28.
52. Tongren J.E., Drakeley C.J., McDonald S.L., Reyburn H.G., Manjurano A., Nkya W.M., Lemnge M.M., Gowda C.D., Todd J.E., Corran P.H., Riley E.M. Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. Infect. Immun. 2006, 74:257-264.
53. Wahlgren M., Berzins K., Perlmann P., Persson M. Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Clin. Exp. Immunol. 1983, 54:135-142.